As the food and beverage industry continues to evolve, there are several trends and innovations shaping the way food is manufactured, processed, distributed, and marketed. One area of focus is the development of infant formula that closely mimics the composition and structure of human milk (HM) to enhance cognitive health in children.
A recent study conducted by Danone Nutricia Research, published in ‘Frontiers in Nutrition,’ explored the effects of an infant formula that replicated HM lipid composition and milk fat globule structure on childhood cognitive performance. The researchers hypothesized that differences in milk lipid composition and milk fat globule structure could contribute to the positive association between breastfeeding and neurocognitive development in infants and children.
The findings revealed that infants fed the HM mimicking formula had fatty acid ratios closer to those of breastfed infants and demonstrated higher cognitive health scores compared to those fed standard formula. The study concluded that exposure to an infant formula that closely resembles HM positively affects child neurocognitive development, potentially due to differences in omega-3 fatty acid status during the early months of life.
Breastfeeding has long been associated with improved neurocognitive development, primarily due to the unique composition of lipids found in HM. These lipids, such as docosahexaenoic acid (DHA), play a crucial role in neuronal development. Dietary supply of long-chain polyunsaturated fatty acids (LCPUFA) during the first year of life has also been linked to child neurocognitive outcomes.
The lipid composition and structure in HM differ from those in infant formula, which often relies on bovine milk-based proteins and vegetable oils for its lipid fraction. While raw bovine milk shares some similarities in lipid globule size and membrane structure with HM, common manufacturing processes disrupt these structural features in infant formula.
To bridge the gap between HM and formula, advancements have been made to incorporate dairy lipids and milk fat globule membrane (MFGM)-derived ingredients in infant formula production. By using larger lipid droplets coated with phospholipids, the structural properties of HM can be replicated. These modifications have shown potential in improving lipid digestion, absorption, and infant neurocognitive development.
In a randomized controlled trial, infants exposed to an infant formula with large, milk phospholipid-coated lipid droplets and dairy lipids exhibited improved cognitive function during childhood, approaching the levels seen in breastfed children. At age 5, they demonstrated higher scores in tests measuring executive function.
The study also highlighted the potential mechanisms behind these cognitive improvements. The unique lipid composition of the infant formula led to better accumulation of essential fatty acids in the brain during the first year of life, as evidenced by improved n-3 LCPUFA accumulation and a lower n-6 to n-3 LCPUFA ratio in erythrocyte membranes. Erythrocyte composition serves as an indirect biomarker for LCPUFA in neuronal tissue.
While the study has its strengths, like long-term follow-up and repeated cognitive assessments, there are also limitations such as a relatively small sample size and the exploratory nature of the investigation. Nonetheless, these findings shed light on the potential of infant formula that closely mimics HM to support better cognitive development in formula-fed infants.
Overall, the food and beverage industry is witnessing advancements in formula development, aiming to produce formulas that offer similar benefits to breastfeeding while meeting regulatory and sustainability standards. By understanding the role of lipid composition and structure in cognitive health, manufacturers can continue to innovate and create formula options that optimize neurocognitive development in infants and children
